{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:19:44Z","timestamp":1789795184920,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.urology.2016.08.022","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T16:21:10Z","timestamp":1472055670000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy"],"prefix":"10.1016","volume":"99","author":[{"given":"Michael","family":"Fenstermaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Mendhiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Bjurlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Rosenkrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.08.022_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature","volume":"68","author":"Futterer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2016.08.022_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","article-title":"Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies","volume":"66","author":"Pokorny","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","article-title":"A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial","volume":"66","author":"Wysock","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.juro.2012.08.095","article-title":"Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device","volume":"189","author":"Sonn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.urology.2010.06.008","article-title":"Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans","volume":"77","author":"Abd","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.08.022_bib0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2012.09.033","article-title":"Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care","volume":"63","author":"Ukimura","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0050","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.2214\/AJR.12.10173","article-title":"Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI","volume":"201","author":"Rosenkrantz","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urology.2016.08.022_bib0055","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.juro.2013.02.072","article-title":"Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing","volume":"189","author":"Bjurlin","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MOU.0000000000000133","article-title":"Urinary biomarkers for prostate cancer","volume":"25","author":"Wei","year":"2015","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","article-title":"Contemporary role of prostate cancer antigen 3 in the management of prostate cancer","volume":"60","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.08.022_bib0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.08.022_bib0085","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/j.juro.2014.02.2081","article-title":"MP67-14 predictive value of negative 3T multiparametric prostate MRI on 12 core biopsy results","volume":"191","author":"Wysock","year":"2014","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516305350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516305350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T01:29:57Z","timestamp":1536456597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516305350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":16,"alternative-id":["S0090429516305350"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.08.022","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}